These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10103290)

  • 21. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review.
    Benitz WE; Gould JB; Druzin ML
    Pediatrics; 1999 Jun; 103(6):e78. PubMed ID: 10353975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of group B Streptococcus infection in neonates.
    Logsdon BA; Casto DT
    Ann Pharmacother; 1997; 31(7-8):897-906. PubMed ID: 9220054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group.
    Rosenstein NE; Schuchat A
    Obstet Gynecol; 1997 Dec; 90(6):901-6. PubMed ID: 9397099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrapartum chemoprophylaxis for group B streptococcus infection to prevent neonatal disease: who should be treated?
    Philipson EH; Herson VC
    Am J Perinatol; 1996 Nov; 13(8):487-90. PubMed ID: 8989480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of fever in labor and risk of neonatal sepsis.
    Towers CV; Yates A; Zite N; Smith C; Chernicky L; Howard B
    Am J Obstet Gynecol; 2017 Jun; 216(6):596.e1-596.e5. PubMed ID: 28216060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-onset neonatal group B streptococcal sepsis: economics of various prevention strategies.
    Garland SM; Kelly N
    Med J Aust; 1995 Apr; 162(8):413-7. PubMed ID: 7746174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of a cost-effective strategy to prevent neonatal early-onset group B haemolytic streptococcus disease in the Netherlands.
    Kolkman DG; Rijnders ME; Wouters MG; van den Akker-van Marle ME; van der Ploeg CK; de Groot CJ; Fleuren MA
    BMC Pregnancy Childbirth; 2013 Jul; 13():155. PubMed ID: 23899463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of group B streptococcal infection.
    Noya FJ; Baker CJ
    Infect Dis Clin North Am; 1992 Mar; 6(1):41-55. PubMed ID: 1578122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
    Verani JR; McGee L; Schrag SJ;
    MMWR Recomm Rep; 2010 Nov; 59(RR-10):1-36. PubMed ID: 21088663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study.
    Schuchat A; Zywicki SS; Dinsmoor MJ; Mercer B; Romaguera J; O'Sullivan MJ; Patel D; Peters MT; Stoll B; Levine OS
    Pediatrics; 2000 Jan; 105(1 Pt 1):21-6. PubMed ID: 10617699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-onset neonatal group B streptococcal infections in New Zealand 1998-1999.
    Grimwood K; Darlow BA; Gosling IA; Green R; Lennon DR; Martin DR; Stone PR
    J Paediatr Child Health; 2002 Jun; 38(3):272-7. PubMed ID: 12047696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A trial of preventing early- and late-onset Group B streptococcal sepsis with combined intrapartum chemoprophylaxis and universal neonatal screening.
    Bertini G; Dani C; Cianciulli D; Rubaltelli FF; Nicoletti P
    J Perinat Med; 2006; 34(5):420-4. PubMed ID: 16965231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
    Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
    Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of neonatal group B streptococcal infection.
    Keenan C
    Am Fam Physician; 1998 Jun; 57(11):2713-20, 2725. PubMed ID: 9636335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of early-onset Group B Streptococcal disease - the Northern Ireland experience.
    Eastwood KA; Craig S; Sidhu H; Boyle M; Gannon C; Ong G; Lupari M; Craven A; Magowan S; Ashe RG
    BJOG; 2015 Feb; 122(3):361-7. PubMed ID: 24861487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost Effectiveness of Latest Recommendations for Group B Streptococci Screening in the United States.
    Williams M; Zantow E; Turrentine M
    Obstet Gynecol; 2020 Apr; 135(4):789-798. PubMed ID: 32168204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of universal antenatal screening for group B streptococcus.
    Van Dyke MK; Phares CR; Lynfield R; Thomas AR; Arnold KE; Craig AS; Mohle-Boetani J; Gershman K; Schaffner W; Petit S; Zansky SM; Morin CA; Spina NL; Wymore K; Harrison LH; Shutt KA; Bareta J; Bulens SN; Zell ER; Schuchat A; Schrag SJ
    N Engl J Med; 2009 Jun; 360(25):2626-36. PubMed ID: 19535801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants.
    Bromberger P; Lawrence JM; Braun D; Saunders B; Contreras R; Petitti DB
    Pediatrics; 2000 Aug; 106(2 Pt 1):244-50. PubMed ID: 10920146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.